DBV Technologies Elects George Horner as Non-executive Chairman of the Board of Directors to Advance the Clinical Development of VIASKIN® Peanut, the World’s First Epicutaneous Skin Patch for Desensitization of Peanut Allergy
PARIS--(BUSINESS WIRE)--DBV Technologies, an emerging biotechnology company, announced today that its board of directors has elected George F. Horner III as non-executive chairman, effective immediately.